Anti—tumor necrosis factor therapy abrogates autoimmune demyelination

Annals of Neurology

Volumn 30, Issue 5, 1991, Pages 694-700

  Selmaj, K ^a,b,c   Raine, C S ^a,b,c   Cross, A H ^a,b,c  

^a Departments of Pathology   (United States)

^b Neurology ^*  (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; DEMYELINATION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIBODIES; AUTOIMMUNE DISEASES; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOTHERAPY, ADOPTIVE; MICE; MICE, INBRED STRAINS; MYELIN BASIC PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR;

EID: 0026094706     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410300510     Document Type: Article

References (36)

1. − T lymphocytes
2. Lyt‐1 cells mediate acute murine experimental allergic encephalomyelitis
3. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells
4. Tumor necrosis factor and lymphotoxin genes map close to H‐2D in the mouse major histocompatibility complex
5. Tumor necrosis factor identified in multiple sclerosis brain
6. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
7. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
8. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes
9. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
10. An analysis of the role of tumor necrosis factor in the phenotypic expression of actively induced experimental allergic orchitis and experimental allergic encephalomyelitis
11. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species
12. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
13. Experimental autoimmune encephalomyelitis: augmentation of demyelination by different myelin lipids
14. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor
15. Generation and characterization of hamster monoclonal antibody that neutralizes murine tumor necrosis factors
16. Enzyme linked immunosorbent assays (ELISA)
17. Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse
18. Endothelial cell activation induced by tumor necrosis factor and lymphotoxin
19. Recombinant human tumor necrosis factor increases in RNA levels and surface expression of HLA‐A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro
20. Effects of tumor necrosis factor on the interferon‐gamma‐induced major histocompatibility complex class II antigen expression by human endothelial cells
21. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL‐1 or lipopolysaccharide
22. Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon‐gamma, tumor necrosis factor and interleukin‐1
23. Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor
24. Activation of cultured endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species
25. Evidence that leukocyte function‐associated antigen‐1 is involved in recirculation and homing of human lymphocytes via high endothelial venules
26. − T cell subsets and Blymphocytes to the central nervous system of mice with acute experimental allergic encephalomyelitis
27. 14C‐labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis
28. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)‐alpha: induction of the receptors on human T cells and TNF‐alpha mediated enhancement of T cell response
29. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti‐CD3 antibody
30. Identification and characterization of a membrance‐bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor/cachectin
31. A novel addition of the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells
32. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF
33. Enhancement of antigen‐and mitogen‐induced human T lymphocyte proliferation by tumor necrosis factor
34. Effect of tumor necrosis factor alpha on mitogen activated human B cells
35. Inhibition of cytotoxic T cell development by transforming growth factor‐beta and reversal by recombinant tumor necrosis factor alpha
36. Experimental allergic encephalomyelitis in the absence of classical delayed‐type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin‐2 receptor‐positive cells infiltrating the central nervous system